Lazertinib trials for Lung cancer

All Lazertinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Lazertinib for Lung cancer

• A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
  NCT06156527 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 5 locations
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT06667076 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 203 locations
• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
  NCT05498428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 110 locations
• A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
  NCT07586202 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
  NCT06106802 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Lazertinib for Lung cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.